title: Next-Generation Protein Therapeutics Summit conference report.
abstract: The 2011 Next-Generation Protein Therapeutics Summit integrated five promising strategic approaches to designing and realizing the next generations of protein and biologic drugs. The conference sessions focused on non-antibody and antibody therapeutics, innovations in improving the physicochemical properties of these drugs, routes of administration, methodologies for reducing unwanted immunogenic reactions, and novel drugs from non-natural amino acids.
authors: MannKind Corporation, I Casper Street, Danbury, CT 06810, USA. aleone-bay@mannkindcorp.com
authors: Andrea
authors: A
authors: Leone-Bay
mesh_terms: D000818:Animals; D000906:Antibodies / Q000008:administration & dosage* / Q000009:adverse effects; D015195:Drug Design; D006801:Humans; D011506:Proteins / Q000008:administration & dosage* / Q000009:adverse effects
chemical_list: D000906:Antibodies; D011506:Proteins